Association of Baseline Urinary Metabolic Biomarkers with ADPKD Severity in TAME-PKD Clinical Trial Participants

Abstract

Urine excretion of two key glycolytic enzymes correlated with autosomal dominant polycystic kidney disease (ADPKD) severity (height-adjusted total kidney volume and eGFR) at baseline in the TAME-PKD study population.

Document Details

Document Type
Pub Defense Publication
Publication Date
May 01, 2021
Source ID
10.34067/kid.0005962020

Entities

People

  • Andrew D. Althouse
  • Biagio Saitta
  • Dana C. Miskulin
  • Hui Li
  • Kaleab Z. Abebe
  • Kenneth Hallows
  • Kyongtae T. Bae
  • Ronald D. Perrone
  • Stephen L. Seliger
  • Terry J. Watnick

Organizations

  • National Center for Advancing Translational Sciences
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • Tufts Medical Center
  • United States Department of Defense
  • University of Maryland
  • University of Pittsburgh
  • University of Southern California

Tags

Fields of Study

  • Medicine

Readers

  • Molecular and Cellular Biology
  • Psychological Intervention/Treatment for Stress, Anxiety, PTSD, and Related Emotional and Cognitive Health Symptoms.
  • Toxicology/Environmental Toxicology